Synthesis, characterization and antitumor properties of two highly cytotoxic ruthenium(iii) complexes with bulky triazolopyrimidine ligands.

about

Synthesis, characterization and antitumor properties of two highly cytotoxic ruthenium(iii) complexes with bulky triazolopyrimidine ligands.

Item

http://www.wikidata.org/entity/Q39208851

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Synthesis, characterization an ...... ky triazolopyrimidine ligands.

@en

Synthesis, characterization an ...... ky triazolopyrimidine ligands.

@nl

type

Item

label

Synthesis, characterization an ...... ky triazolopyrimidine ligands.

@en

Synthesis, characterization an ...... ky triazolopyrimidine ligands.

@nl

prefLabel

Synthesis, characterization an ...... ky triazolopyrimidine ligands.

@en

Synthesis, characterization an ...... ky triazolopyrimidine ligands.

@nl

P1476

Synthesis, characterization an ...... ky triazolopyrimidine ligands.

@en

P2093

Iwona Łakomska

http://www.w3.org/2001/XMLSchema#string

Julia Jezierska

http://www.w3.org/2001/XMLSchema#string

Marzena Fandzloch

http://www.w3.org/2001/XMLSchema#string

Tadeusz Lis

http://www.w3.org/2001/XMLSchema#string

Tadeusz Muzioł

http://www.w3.org/2001/XMLSchema#string

P2860

A short history of SHELX

Determination and analysis of the 2 A-structure of copper, zinc superoxide dismutase

New colorimetric cytotoxicity assay for anticancer-drug screening

(Aminoethanol)dichloroplatinum(II) complexes: influence of the hydroxyethyl moiety on 5'-GMP and DNA binding, intramolecular stability, the partition coefficient and anticancer activity.

Appraisal of the redox behaviour of the antimetastatic ruthenium(III) complex [ImH][RuCl(4)(DMSO)(Im)], NAMI-A.

Synthesis and chemical-pharmacological characterization of the antimetastatic NAMI-A-type Ru(III) complexes (Hdmtp)[trans-RuCl4(dmso-S)(dmtp)], (Na)[trans-RuCl4(dmso-S)(dmtp)], and [mer-RuCl3(H2O)(dmso-S)(dmtp)] (dmtp = 5,7-dimethyl[1,2,4]triazolo[1

Lipophilic ruthenium complexes with tuned cell membrane affinity and photoactivated uptake.

Biopharmaceutics and pharmacokinetics in drug research.

From bench to bedside--preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A).

KP1019, a new redox-active anticancer agent--preclinical development and results of a clinical phase I study in tumor patients.

P304

6219-6226

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1039/C2DT32216A

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23328694

http://www.w3.org/2001/XMLSchema#string